Pulmonx (LUNG) Total Current Liabilities (2019 - 2025)

Pulmonx (LUNG) has 7 years of Total Current Liabilities data on file, last reported at $20.1 million in Q4 2025.

• On a quarterly basis, Total Current Liabilities fell 17.92% year-over-year to $20.1 million in Q4 2025; TTM through Dec 2025 was $20.1 million, a 17.92% decrease from a year earlier, with the FY2025 full-year figure at $20.1 million, down 17.92% from the prior year.
• Total Current Liabilities for Q4 2025 stood at $20.1 million, down from $22.9 million in the prior quarter.
• Over the last five years, Total Current Liabilities for LUNG reached as high as $24.9 million in Q1 2025 and fell as low as $14.0 million in Q1 2021.
• Historically, Total Current Liabilities has averaged $20.0 million across 5 years, with a median of $20.3 million in 2022.
• Across the five-year window, Total Current Liabilities jumped 46.41% in 2021 and dropped 17.92% in 2025, its largest moves.
• Year by year, Total Current Liabilities stood at $17.6 million in 2021, then gained by 5.37% to $18.5 million in 2022, then gained by 25.23% to $23.2 million in 2023, then grew by 5.53% to $24.4 million in 2024, then fell by 17.92% to $20.1 million in 2025.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $20.1 million in Q4 2025, $22.9 million in Q3 2025, and $22.4 million in Q2 2025.